Intelligence Feed event · Equity · 2026-09-26

    Staar Surgical authorizes $50M share repurchase program

    Question

    Staar Surgical authorizes $50M share repurchase program

    Direct answer

    Staar Surgical announced that its board has approved a $50 million share repurchase authorization. Management cited ongoing free cash flow generation and balance sheet liquidity as drivers behind the decision to repurchase undervalued equity. Shares of STAA climbed 7.5% following the disclosure, reflecting market endorsement of management's capital allocation shift toward direct equity support.

    Original publisher
    Market Ontology
    Evidence through
    2026-09-26
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Staar Surgical authorizes $50M share repurchase program”, revision 1, evidence through 2026-09-26. https://marketontology.com/market-events/2026-09-26/staar-surgical-authorizes-50m-share-repurchase-program-61b9aa

    EQUITY
    Staar Surgical authorizes $50M share repurchase program
    Staar Surgical announced that its board has approved a $50 million share repurchase authorization. Management cited ongoing free cash flow generation and balance sheet liquidity as drivers behind the decision to repurchase undervalued equity. Shares of STAA climbed 7.5% following the disclosure, reflecting market endorsement of management's capital allocation shift toward direct equity support.
    STAA
    Impact
    60
    SEP 26
    SIG
    90%
    STAA
    Staar Surgical authorizes $50M share repurchase program
    Staar Surgical announced that its board has approved a $50 million share repurchase authorization. Management cited ongoing free cash flow generation and balance sheet liquidity as drivers behind the decision to repurchase undervalued equity. Shares of STAA climbed 7.5% following the disclosure, reflecting market endorsement of management's capital allocation shift toward direct equity support.
    → Direct authorization of $50M in equity repurchases creates corporate bid support and reduces diluted share count for STAA.
    Impact
    Staar Surgical announced that its board has approved a $50 million share repurchase authorization. Management cited ongoing free cash flow generation and balance sheet liquidity as drivers behind the decision to repurchase undervalued equity. Shares of STAA climbed 7.5% following the disclosure, reflecting market endorsement of management's capital allocation shift toward direct equity support.
    Affected
    STAA
    Transmission
    Direct authorization of $50M in equity repurchases creates corporate bid support and reduces diluted share count for STAA.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    STAAcorporate balance sheet liquidity deployment into share repurchasesUp1-5dStaar Surgical announced a $50 million share buyback program authorized by its board, causing the stock to surge 7.5%.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    AssetCallBase close+1 day+5 days+20 days
    STAAUpagreed20.51 2026-09-25+1.76%+9.56%Pending

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month